Latest Asx Company Filings News

Holista Colltech has closed its ASIC penalty chapter with a $900K final payment, raised $1.53 million through convertible notes, and reported a 10.9% year-on-year sales increase driven by its Dietary Supplements division.

4DMedical Limited reports a 103% surge in year-to-date revenue, secures major contracts with leading healthcare providers, and advances its CT:VQ™ technology towards FDA clearance.

ReNerve Limited reported a 39% sales increase in Q3 FY25 alongside compelling clinical validation of its NervAlign® Nerve Cuff and strategic international partnerships, positioning the company for broader market penetration.

InteliCare Holdings has secured a binding agreement to trial its AI-driven platform at mecwacare’s Trescowthick Centre, marking a significant step in its commercialisation strategy within Victoria’s aged care sector.

Uscom Limited reported a 14% rise in Q3 customer receipts to $0.73 million, even as cash reserves dropped 38% to $1.34 million, reflecting increased operating costs and global market pressures.

IDT Australia reports a robust 30% jump in quarterly revenue to $4.1 million, driven by strong contract wins and a $62 million pipeline of open proposals, signaling sustained growth in pharmaceutical manufacturing.

Platina Resources has completed diamond drilling at its Xanadu Deeps gold target and is gearing up for further aircore drilling at Challa and Beete projects, maintaining a strong cash position of A$11.77 million.

Codrus Minerals advances its diversified exploration portfolio with permitting progress at Bull Run and promising uranium geochemical results at Jasper Wedge, while managing costs amid challenging gold markets.

Terra Uranium Limited has expanded its exploration portfolio by acquiring LCT Metals, adding tin and precious metals projects in New South Wales, while advancing uranium exploration in Canada’s Athabasca Basin through strategic partnerships and drill-ready targets.

Alexium International Group reported a challenging Q3 FY2025 with lower revenues due to softness in the US bedding market, while making significant technological strides and maintaining a solid funding position.

Nova Eye Medical reported a 27% rise in Q3FY25 sales excluding China, driven by record US performance and a sharp reduction in glaucoma segment losses. The company confirmed FY25 revenue guidance and unveiled plans to expand its iTrack™ technology into ocular drug delivery.

Streamplay Studio Limited reported a remarkable 827% increase in customer receipts for Q3 2025, driven by the full integration of Noodlecake Studios. With a robust cash balance of A$7.7 million and no debt, the company is well-positioned to accelerate growth across cloud gaming, game publishing, and emerging markets.